Joint Commission Compliance with USP Standards
Wednesday, September 25, 2019 2:55 PM
As reported yesterday in the KHA News blog, the United States Pharmacopeia (USP) notified stakeholders that it is postponing the official effective dates of several new and revised standards pertaining to pharmaceutical handling until further notice while it reviews appeals to the standards. KHA contacted the Joint Commission this morning to clarify how this would impact their surveys.
Their official statement has not yet been released; however, until the Joint Commission knows more about the delay in implementation of USP 797 and 800 standards, there will be no changes to the way they survey medication compounding.
KHA will distribute any updated information to members as soon as it is available.